Endotoxin Testing Requirements for Haemodialysis
Endotoxin contamination is the most critical safety concern in haemodialysis. Endotoxins can cause severe pyrogenic reactions, chronic inflammation, and long-term complications in patients undergoing haemodialysis. Because dialysis patients are exposed to large volumes of dialysis fluid several times per week, ensuring strict control of endotoxin levels is essential. International standards — particularly the ISO 23500 and ISO 13959 series — set clear requirements for water, concentrates, and dialysis fluids used in haemodialysis to protect patient safety.
Endotoxin Limits in Dialysis Water
Dialysis water is the main component for preparing dialysis fluid and reprocessing dialysers. According to ISO 13959:2015 and ISO 23500:2024, dialysis water must meet a maximum endotoxin limit of 0.25 EU/mL, with an action level set at 0.125 EU/mL. These thresholds are based on the recognition that dialysis fluid is an excellent growth medium for microorganisms, making early detection and intervention essential. For ultrapure dialysis water, required in high-flux haemodialysis and online convective therapies, the standard is far stricter, with an endotoxin concentration limit of 0.03 EU/mL.
Endotoxin Limits in Dialysis Fluid
Dialysis fluid (or dialysate) is prepared by mixing treated water with concentrates. The maximum allowable endotoxin concentration in standard dialysis fluid is 0.5 EU/mL, with an action level of 0.25 EU/mL. However, for ultrapure dialysis fluid, often preferred for reducing chronic inflammation and improving long-term patient outcomes, the limit is <0.03 EU/mL. Achieving these limits often requires the use of validated endotoxin retentive filters in dialysis machines, which can eliminate the need for frequent testing if maintained according to manufacturer instructions.
Concentrates and Endotoxin Testing Challenges
Dialysis concentrates, particularly bicarbonate-based solutions, pose unique challenges for endotoxin testing. ISO 23500 highlights that bicarbonate concentrates can inhibit the Limulus Amebocyte Lysate (LAL) assay, the most widely used method for endotoxin detection. This inhibition is due to high solute concentration and pH, which interfere with both gel-clot and kinetic LAL assays. To overcome this, concentrates must be diluted—typically at least 1:16, and often at 1:20—when using highly sensitive assays to ensure reliable endotoxin detection.
Testing Methods and Alternatives
The LAL assay remains the gold standard for endotoxin testing. However, alternative assays such as recombinant Factor C (rFC) are increasingly recognized as valid substitutes, provided equivalence is demonstrated. Testing protocols emphasize the use of endotoxin-free containers, immediate analysis of samples (ideally within four hours), and validated storage conditions to avoid false positive or negative results. Regular monitoring and trending are required, especially for water distribution systems and bicarbonate concentrate storage tanks.
Surveillance and Risk Management
Routine monitoring is central to preventing endotoxin exposure in dialysis patients. ISO standards require:
Regular surveillance of water storage and distribution systems, with trend analysis to detect gradual increases in endotoxin levels.
Weekly testing of bicarbonate concentrate during initial use, which may be reduced to monthly once stability is demonstrated.
Point-of-use sampling at dialysis machines and mixing tanks, ensuring contamination is detected where patients are directly at risk.
Endotoxin retentive filters must also be validated under real operating conditions, as performance can vary widely depending on feedwater quality and system configuration. Some guidelines suggest that filters should reduce bacterial counts by at least 10^7 and endotoxin levels by 10^3, though consensus on minimum performance criteria is still lacking.
Clinical Relevance
Even trace levels of endotoxin can cross dialysis membranes or generate pro-inflammatory cytokines that contribute to long-term morbidity. The cumulative exposure from dialysis sessions three times per week makes strict compliance with ISO limits essential. The move towards ultrapure dialysis fluid reflects growing recognition that lowering endotoxin exposure improves outcomes, reducing risks of amyloidosis, cardiovascular complications, and chronic inflammation in dialysis patients.
Conclusion
Endotoxin testing requirements for haemodialysis are designed to safeguard patients from acute and chronic complications. International standards define strict limits for dialysis water, fluid, and concentrates, supported by validated analytical methods such as LAL and rFC assays. Surveillance, regular testing, and risk-based management strategies are critical to maintaining compliance. As dialysis technologies advance, the adoption of ultrapure water and endotoxin-retentive filters is becoming more widespread, ensuring higher safety margins and improved patient care.
References
European Committee for Standardization. (2015). EN ISO 13959:2015. Water for haemodialysis and related therapies. International Organization for Standardization.
International Organization for Standardization. (2024). BS EN ISO 23500:2024. Preparation and quality management of fluids for haemodialysis and related therapies (Parts 1–5). ISO.
Karkar, A., Abdelrahman, M., & Locatelli, F. (2015). Basic principles and current status of hemodiafiltration. Clinical Kidney Journal, 8(3): 359–368. https://doi.org/10.1093/ckj/sfv024
Schindler, R., Beck, W., Deppisch, R., Aussieker, M., Wilde, A., Göhl, H., & Frei, U. (2004). Short bacterial DNA fragments: Detection in dialysate and induction of cytokines. Journal of the American Society of Nephrology, 15(12): 3207–3214. https://doi.org/10.1097/01.ASN.0000145875.48592.C3